Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

SZSE Ticker: 002004

Huapont Life Sciences Co., Ltd.

华邦生命健康股份有限公司

华邦健康

HUAPONT LIFESCIENCES

Listing Date: 2004-06-25

Board: SME

Industry Classification: Manufacturing

What are the skin and beauty concept stocks in 2022? List and ranking of leading stocks in skin and beauty (stock code)

  • Post date May 8, 2022 — 10:55 Post Lock Login to View

Read More

Winbond Health: The longevity API production base is currently undergoing equipment debugging and other work and is expected to be put into production within this year.

  • Post date May 7, 2022 — 19:28 Post Lock Login to View

Read More

Winbond Health: In terms of medical beauty business, the company has launched more than 20 products, which are still in the early stage of marketing.

  • Post date May 7, 2022 — 19:28 Post Lock Login to View

Read More

Winbond Health: At present, the company is not engaged in the research and development of new crown drugs.

  • Post date May 7, 2022 — 19:15 Post Lock Login to View

Read More

Winbond Health: Currently the company is not engaged in the research and development of new crown drugs

  • Post date May 7, 2022 — 19:14 Post Lock Login to View

Read More

Winbond Health: The company's soil and water preparation production base has been completed and put into production in 2020

  • Post date May 7, 2022 — 19:14 Post Lock Login to View

Read More

[Transaction stock] Glyphosate sector rose, Jiangshan shares (600389.CN) rose 10.0%-Hong Kong stocks-financial circle

  • Post date May 5, 2022 — 16:15 Post Lock Login to View

Read More

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

  • Post date May 1, 2022 — 04:00 Post Lock Login to View

Read More

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks will increase in revenue and net profit, and BeiGene will become the "loss king"-Stock Channel-Hexun.com

  • Post date May 1, 2022 — 04:00 Post Lock Login to View

Read More

Intensified fluctuations in the RMB exchange rate, the fundamentals of export-oriented listed companies are expected to improve – yqqlm

  • Post date April 30, 2022 — 13:15 Post Lock Login to View

Read More

RMB exchange rate fluctuations intensify export-oriented listed companies or "return blood"

  • Post date April 29, 2022 — 23:25 Post Lock Login to View

Read More

Winbond Health: In terms of traditional Chinese medicine research and development, Hanwang Pharmaceutical, which has invested and participated in the company's investment and equity participation, operates each economic network.

  • Post date April 27, 2022 — 11:13 Post Lock Login to View

Read More

Winbond Health: The research and development of traditional Chinese medicine is mainly operated by its subsidiary Hanwang Pharmaceuticals_ Oriental Fortune Net

  • Post date April 27, 2022 — 11:12 Post Lock Login to View

Read More

ICBC's New Opportunity to Flexibly Allocation Mixed Net Value of C: 7.83% Gains_Sina Finance_Sina Net

  • Post date April 26, 2022 — 06:58 Post Lock Login to View

Read More

Important Tips Financing Customers Favorite Stock Exposure_Oriental Fortune Net

  • Post date April 21, 2022 — 10:37 Post Lock Login to View

Read More

Over 80% of 136 pharmaceutical and biological companies plan to distribute dividends of over 100 million yuan to 58 companies

  • Post date April 6, 2022 — 03:20 Post Lock Login to View

Read More

136 listed pharmaceutical and biological companies announced their annual reports: more than 80% of them plan to distribute cash dividends, and 58 companies will distribute cash dividends of more than 100 million yuan

  • Post date April 5, 2022 — 21:30 Post Lock Login to View

Read More

Warcraft password

  • Post date April 5, 2022 — 06:39 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.